Hira Ateeq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hira Ateeq has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Afaf Zia
Department of Periodontics and Community Dentistry, Dr. Ziauddin Ahmed Dental College (DRZADC), Aligarh Muslim University (AMU), Uttar Pradesh (UP), Aligarh, India
3 shared publications - Qayyum Husain
Aligarh Muslim University
3 shared publications - Mohd Sajid Khan
Department of Biosciences, Integral University, Lucknow, India
2 shared publications - Aabgeena Naeem
Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, U.P., India
1 shared publication - Afshan Bey
Department of Periodontics, Dr. Ziauddin Ahmad Dental College, Faculty of Medicine, Aligarh Muslim University, Aligarh, India
1 shared publication - Hamna Jamaeel
Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University
1 shared publication
Latest Publications
- 4 July 2026
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- p. 1-10
Green fabrication and antibacterial evaluation of lysozyme-immobilized cysteine-capped silver nanoparticles
The broad-spectrum antibacterial properties of silver nanoparticles (AgNPs) are attracting increasing attention as a means to combat drug-resistant infections. Herein, we describe the green production of AgNPs with minimal environmental impact by using plant components as reducing agents. Hibiscus rosa sinensis flower extract was used to form AgNPs from a 1 mM solution of silver nitrate. The NPs were cysteine-stabilized, on which hen egg white lysozyme was immobilized. The NPs, as analyzed by SEM, were nearly spherical. The size of the Cys-NPs, as measured by TEM, ranged from 12.52 nm to 27.20 nm, with an average size of 22.83, and the size of Lys-Cys-AgNPs ranged from 16.32 nm to 44.60 nm, with an average size of 30.30 nm. The enzyme assay for Lys-Cys-AgNPs demonstrated an effective activity of approximately 80.8 ± 3.6% compared to free lysozyme, and the immobilization efficiency was calculated to be 66.8%. MIC of Lys-Cys-AgNPs against E. coli (8.5 μg/mL), P. aeruginosa (12 μg/mL), S.aureus (6 μg/mL) and S. mutans (5.5 μg/mL). The antibacterial activity of Lys-Cys-AgNPs combined with streptomycin was evaluated against E. coli, P. aeruginosa, S. aureus, and S. mutans using the agar well diffusion method. The zones of inhibition observed were 11.00 ± 0.31 mm, 8.00 ± 0.11 mm, 8.00 ± 0.14 mm and 18.00 ± 0.65 mm, respectively. Green-synthesized, cysteine-stabilized silver nanoparticles functionalized with lysozyme demonstrated enhanced antibacterial efficacy against both Gram-positive and Gram-negative pathogens. These findings highlight their potential as an eco-friendly and effective nanobiotherapeutic strategy to combat drug-resistant infections.
- 4 July 2026
- Published by Taylor & Francis in Preparative Biochemistry & Biotechnology
- p. 1-10
Green fabrication and antibacterial evaluation of lysozyme-immobilized cysteine-capped silver nanoparticles
The broad-spectrum antibacterial properties of silver nanoparticles (AgNPs) are attracting increasing attention as a means to combat drug-resistant infections. Herein, we describe the green production of AgNPs with minimal environmental impact by using plant components as reducing agents. Hibiscus rosa sinensis flower extract was used to form AgNPs from a 1 mM solution of silver nitrate. The NPs were cysteine-stabilized, on which hen egg white lysozyme was immobilized. The NPs, as analyzed by SEM, were nearly spherical. The size of the Cys-NPs, as measured by TEM, ranged from 12.52 nm to 27.20 nm, with an average size of 22.83, and the size of Lys-Cys-AgNPs ranged from 16.32 nm to 44.60 nm, with an average size of 30.30 nm. The enzyme assay for Lys-Cys-AgNPs demonstrated an effective activity of approximately 80.8 ± 3.6% compared to free lysozyme, and the immobilization efficiency was calculated to be 66.8%. MIC of Lys-Cys-AgNPs against E. coli (8.5 μg/mL), P. aeruginosa (12 μg/mL), S.aureus (6 μg/mL) and S. mutans (5.5 μg/mL). The antibacterial activity of Lys-Cys-AgNPs combined with streptomycin was evaluated against E. coli, P. aeruginosa, S. aureus, and S. mutans using the agar well diffusion method. The zones of inhibition observed were 11.00 ± 0.31 mm, 8.00 ± 0.11 mm, 8.00 ± 0.14 mm and 18.00 ± 0.65 mm, respectively. Green-synthesized, cysteine-stabilized silver nanoparticles functionalized with lysozyme demonstrated enhanced antibacterial efficacy against both Gram-positive and Gram-negative pathogens. These findings highlight their potential as an eco-friendly and effective nanobiotherapeutic strategy to combat drug-resistant infections.
- 13 December 2023
- Published by Springer Nature
- p. 43-64
Role of Biogenic Inorganic Nanomaterials as Drug Delivery Systems
- 13 December 2023
- Published by Springer Nature
- p. 43-64
Role of Biogenic Inorganic Nanomaterials as Drug Delivery Systems
- 29 January 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 1003-1009
Effect of inflammation on bones in diabetic patients with periodontitis via RANKL/OPG system-A review
Purpose Diabetes mellitus and periodontitis are inflammatory diseases, the severity of inflammation results in the progression and persistence of both the disorders and affects bones. Diabetic complications aggravate in diabetic subjects having periodontitis; similarly, diabetic patients are more prone to developing gingivitis and periodontitis. Periodontal and diabetic inflammation disturbs bone homeostasis, which possibly involves both innate and adaptive immune responses. The pathogenic processes that link the two diseases are the focus of much research and it is likely that upregulated inflammation arising from each condition adversely affects the other. RANKL/OPG pathway plays a prominent role in periodontal and diabetic inflammation and bone resorption. Method This review article summarises the literature on the link between inflammatory cytokines and the prevalence of disturbed bone homeostasis in diabetic patients with periodontitis. An extensive search was done in PubMed, Scopus, Medline and Google Scholar databases between April 2003 and May 2021. Result A total of 27 articles, including pilot studies, case–control studies, cross-sectional studies, cohort studies, randomized control trials, longitudinal studies, descriptive studies and experimental studies, were included in our literature review. Conclusion Since RANKL/OPG are cytokines and have immune responses, regulating these cytokines expression will help control diabetes, periodontitis and bone homeostasis. The growing evidence of bone loss and increased fracture risk in diabetic patients with periodontitis makes it imperative that health professionals carry out planned treatment focusing on monitoring oral health in diabetic patients; bone markers should also be evaluated in patients with chronic periodontitis with an impaired glycemic state.
- 29 January 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 1003-1009
Effect of inflammation on bones in diabetic patients with periodontitis via RANKL/OPG system-A review
Purpose Diabetes mellitus and periodontitis are inflammatory diseases, the severity of inflammation results in the progression and persistence of both the disorders and affects bones. Diabetic complications aggravate in diabetic subjects having periodontitis; similarly, diabetic patients are more prone to developing gingivitis and periodontitis. Periodontal and diabetic inflammation disturbs bone homeostasis, which possibly involves both innate and adaptive immune responses. The pathogenic processes that link the two diseases are the focus of much research and it is likely that upregulated inflammation arising from each condition adversely affects the other. RANKL/OPG pathway plays a prominent role in periodontal and diabetic inflammation and bone resorption. Method This review article summarises the literature on the link between inflammatory cytokines and the prevalence of disturbed bone homeostasis in diabetic patients with periodontitis. An extensive search was done in PubMed, Scopus, Medline and Google Scholar databases between April 2003 and May 2021. Result A total of 27 articles, including pilot studies, case–control studies, cross-sectional studies, cohort studies, randomized control trials, longitudinal studies, descriptive studies and experimental studies, were included in our literature review. Conclusion Since RANKL/OPG are cytokines and have immune responses, regulating these cytokines expression will help control diabetes, periodontitis and bone homeostasis. The growing evidence of bone loss and increased fracture risk in diabetic patients with periodontitis makes it imperative that health professionals carry out planned treatment focusing on monitoring oral health in diabetic patients; bone markers should also be evaluated in patients with chronic periodontitis with an impaired glycemic state.
- Open Access
- 9 June 2021
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 13 (1) , 28-34
Comparative assessment of bone mineral density levels in type 2 diabetic subjects with or without chronic periodontitis: A cross-sectional study
Background. This cross-sectional study investigated the bone mineral density (BMD) in type 2 diabetes mellitus (T2DM) subjects with or without chronic periodontitis (CP). Methods. A total of 120 subjects aged 35‒55, divided equally into four groups: i) T2DM with CP, ii) T2DM without CP, iii) CP alone, and iv) healthy patients, were included in this study. Clinical parameters like plaque index (PI), gingival index (GI), and probing pocket depth (PPD) were recorded. All the participants were evaluated for blood sugar levels using glycated hemoglobin (HbA1c) and BMD by Hologic dual-energy x-ray absorptiometry (DEXA) scan. The association of BMD with clinical periodontal parameters and HbA1c in all groups was investigated using linear correlation analysis (r). Results. The mean value of BMD (0.9020±0.0952 g/cm2) was lower in subjects with both T2DM and CP compared to T2DM and CP alone. BMD was weakly correlated with all the clinical periodontal parameters; a positive correlation was observed between BMD and GI in the T2DM and CP group (r=0.405, P=0.026) and the CP group (r=0.324, P=0.081). A weak positive correlation was observed in BMD and HbA1c in the T2DM group (r=0.261, P=0.13), T2DM and CP group (r=0.007, P=0.970), with a negative correlation to HbA1c in the CP group (r= -0.134, P=0.479). Conclusions: Diabetes mellitus impacts clinical periodontal status and bone mass, and the effect is accentuated when chronic periodontitis is present. Based on the present study, BMD is associated with T2DM and CP, but a weak correlation was observed between BMD and HbA1c and clinical periodontal parameters.
- 9 June 2021
- Published by Maad Rayan Publishing Company in Journal of Advanced Periodontology & Implant Dentistry
- Vol. 13 (1) , 28-34
Open AccessComparative assessment of bone mineral density levels in type 2 diabetic subjects with or without chronic periodontitis: A cross-sectional study
Background. This cross-sectional study investigated the bone mineral density (BMD) in type 2 diabetes mellitus (T2DM) subjects with or without chronic periodontitis (CP). Methods. A total of 120 subjects aged 35‒55, divided equally into four groups: i) T2DM with CP, ii) T2DM without CP, iii) CP alone, and iv) healthy patients, were included in this study. Clinical parameters like plaque index (PI), gingival index (GI), and probing pocket depth (PPD) were recorded. All the participants were evaluated for blood sugar levels using glycated hemoglobin (HbA1c) and BMD by Hologic dual-energy x-ray absorptiometry (DEXA) scan. The association of BMD with clinical periodontal parameters and HbA1c in all groups was investigated using linear correlation analysis (r). Results. The mean value of BMD (0.9020±0.0952 g/cm2) was lower in subjects with both T2DM and CP compared to T2DM and CP alone. BMD was weakly correlated with all the clinical periodontal parameters; a positive correlation was observed between BMD and GI in the T2DM and CP group (r=0.405, P=0.026) and the CP group (r=0.324, P=0.081). A weak positive correlation was observed in BMD and HbA1c in the T2DM group (r=0.261, P=0.13), T2DM and CP group (r=0.007, P=0.970), with a negative correlation to HbA1c in the CP group (r= -0.134, P=0.479). Conclusions: Diabetes mellitus impacts clinical periodontal status and bone mass, and the effect is accentuated when chronic periodontitis is present. Based on the present study, BMD is associated with T2DM and CP, but a weak correlation was observed between BMD and HbA1c and clinical periodontal parameters.